Skip to main content
. 2024 Feb 15:15589447241232015. Online ahead of print. doi: 10.1177/15589447241232015

Table 1.

Patient Characteristics of the Study Cohort (n = 274).

Patient-based variable Total cohort (n = 274) a
Age, y, mean (SD) 50.0 (16.5)
Body mass index, kg/m2, median (IQR) 26.9 (23.7-30.4)
Distressed Communities Index, median (IQR) 23.7 (9.9-46.6)
Female sex, No. (%) 109 (39.8)
Race, No. (%)
 American Indian or Alaska Native 2 (0.8)
 Asian 5 (1.9)
 Black or African American 25 (9.6)
 Hispanic 8 (3.1)
 White 220 (84.6)
English-speaking, No. (%) 265 (97.1)
Comorbidities, No. (%)
 Depression 74 (27.0)
 Anxiety 67 (24.5)
 Diabetes mellitus 34 (12.4)
 Fibromyalgia 12 (4.4)
Current smoker, No. (%) 37 (13.6)
Dominant upper extremity affected, No. (%) 151 (57.2)
Chronic opioid use, No. (%) 18 (6.6)
Chronic pain, No. (%) 30 (11.0)
Recent opioid prescription, No. (%) 33 (12.1)

Note. SD = standard deviation; IQR = interquartile range.

a

Data were missing for the following explanatory variables (n = number of patients with available data): body mass index (n = 273), race (n = 260), language (n = 273), smoking status (n = 273), upper extremity dominance (n = 264), chronic opioid use (n = 273), recent opioid prescription (n = 273), chronic pain (n = 272).